Free public records show Shanghai MicroPort Rhythm MedTech Co., Ltd. in 1 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Shanghai MicroPort Rhythm MedTech Co., Ltd. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
3 active studies led by Shanghai MicroPort Rhythm MedTech Co., Ltd., of 8 in all
Source: ClinicalTrials.gov, Studies with Shanghai MicroPort Rhythm MedTech Co., Ltd. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Studies Shanghai MicroPort Rhythm MedTech Co., Ltd. leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Shanghai MicroPort Rhythm MedTech Co., Ltd. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Shanghai MicroPort Rhythm MedTech Co., Ltd.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Shanghai MicroPort Rhythm MedTech Co., Ltd. is in.
Stories on the topics Shanghai MicroPort Rhythm MedTech Co., Ltd. works in.
Omega-3 supplements are hugely popular. Big trials give mixed answers on whether they protect the heart.
Read
More than half of deaths in low- and middle-income countries come from conditions emergency care could treat…
Read
Road crashes kill about 1.16 million people a year, and more than half of deaths in poorer countries come…
ReadSearch all reports for Shanghai MicroPort Rhythm MedTech Co., Ltd. All companies